These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35735997)

  • 1. Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    Bi W; Chen G; Dang B
    J Virol; 2022 Jul; 96(13):e0068122. PubMed ID: 35735997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing fusion inhibitor peptide against SARS-CoV-2.
    Efaz FM; Islam S; Talukder SA; Akter S; Tashrif MZ; Ali MA; Sufian MA; Parves MR; Islam MJ; Halim MA
    J Comput Chem; 2021 Dec; 42(32):2283-2293. PubMed ID: 34591335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor.
    Zheng M; Cong W; Peng H; Qing J; Shen H; Tang Y; Geng C; Chen S; Zou Y; Zhang WD; Hu HG; Li X
    J Med Chem; 2021 Dec; 64(23):17486-17495. PubMed ID: 34818014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Yang K; Wang C; Kreutzberger AJB; Ojha R; Kuivanen S; Couoh-Cardel S; Muratcioglu S; Eisen TJ; White KI; Held RG; Subramanian S; Marcus K; Pfuetzner RA; Esquivies L; Doyle CA; Kuriyan J; Vapalahti O; Balistreri G; Kirchhausen T; Brunger AT
    Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2210990119. PubMed ID: 36122200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins.
    Polo-Megías D; Cano-Muñoz M; Berruezo AG; Laumond G; Moog C; Conejero-Lara F
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
    Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
    Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2.
    Ling R; Dai Y; Huang B; Huang W; Yu J; Lu X; Jiang Y
    Peptides; 2020 Aug; 130():170328. PubMed ID: 32380200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
    Xia S; Liu M; Wang C; Xu W; Lan Q; Feng S; Qi F; Bao L; Du L; Liu S; Qin C; Sun F; Shi Z; Zhu Y; Jiang S; Lu L
    Cell Res; 2020 Apr; 30(4):343-355. PubMed ID: 32231345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion.
    Gao J; Cao C; Shi M; Hong S; Guo S; Li J; Liang T; Song P; Xu R; Li N
    Phytomedicine; 2023 Sep; 118():154942. PubMed ID: 37421767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2).
    Singh I; Singh S; Ojha KK; Yadav NS
    J Biomol Struct Dyn; 2022; 40(21):11357-11372. PubMed ID: 34379031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.
    Xing L; Xu X; Xu W; Liu Z; Shen X; Zhou J; Xu L; Pu J; Yang C; Huang Y; Lu L; Jiang S; Liu S
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides Derived from the SARS-CoV-2 S2-Protein Heptad-Repeat-2 Inhibit Pseudoviral Fusion at Micromolar Concentrations: The Role of Palmitic Acid Conjugation.
    Düzgüneş N; Tao Z; Zhang Y; Krajewski K
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines.
    Guo L; Lin S; Chen Z; Cao Y; He B; Lu G
    Signal Transduct Target Ther; 2023 May; 8(1):197. PubMed ID: 37164987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enhanced broad-spectrum peptide inhibits Omicron variants in vivo.
    Bi W; Tang K; Chen G; Xie Y; Polizzi NF; DeGrado WF; Yuan S; Dang B
    Cell Rep Med; 2024 Feb; 5(2):101418. PubMed ID: 38340726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen.
    Wang X; Sun L; Liu Z; Xing L; Zhu Y; Xu W; Xia S; Lu L; Jiang S
    Emerg Microbes Infect; 2023 Dec; 12(2):2244084. PubMed ID: 37534910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins.
    Polo-Megías D; Cano-Muñoz M; Berruezo AG; Laumond G; Moog C; Conejero-Lara F
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130132. PubMed ID: 38354919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.
    Xia S; Lan Q; Pu J; Wang C; Liu Z; Xu W; Wang Q; Liu H; Jiang S; Lu L
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30646495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.